Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Human Molecular Genetics|April 12, 2017
Clinical significance of miRNA host gene promoter methylation in prostate cancerKristina Daniunaite, Monika Dubikaityte, Povilas Gibas, et al.
Medicina (Kaunas, Lithuania)|January 13, 2021
Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of MalignancyAlvydas Vėželis, Gediminas Platkevičius, Marius Kinčius, et al.
Oncology Letters|August 1, 2018
ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevityDonatas Stakišaitis, Milda Juknevičienė, Albertas Ulys, et al.
Journal of Cancer Research and Clinical Oncology|October 24, 2021
Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinomaRaimonda Kubiliūtė, Kristina Žukauskaitė, Algirdas Žalimas, et al.
The Prostate|August 24, 2023
Combination of DNA methylation biomarkers with multiparametric magnetic resonance and ultrasound imaging fusion biopsy to detect the local spread of prostate cancerAugustinas Matulevičius, Kristina Žukauskaitė, Rugilė Gineikaitė, et al.
Journal of Clinical Medicine|August 27, 2021
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer PatientsPaulius Bosas, Gintaras Zaleskis, Daiva Dabkevičiene, et al.
Communications Biology|June 28, 2024
Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotypeJustina Zvirblyte, Juozas Nainys, Simonas Juzenas, et al.
International Journal of Molecular Sciences|December 23, 2022
Urine Molecular Biomarkers for Detection and Follow-Up of Small Renal MassesAlgirdas Žalimas, Raimonda Kubiliūtė, Kristina Žukauskaitė, et al.
Biomedicines|March 29, 2023
Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer PatientsTomas Januskevicius, Rasa Sabaliauskaite, Daiva Dabkeviciene, et al.
The Prostate|February 5, 2024
Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open-label, phase 2 trialAlbertas Ulys, Feliksas Jankevicus, Mindaugas Jievaltas, et al.
Pageof 5